<DOC>
	<DOCNO>NCT01278095</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics solid capsule formulation GLPG0555 nanosuspension , assess safety tolerability single dose GLPG0555 .</brief_summary>
	<brief_title>Oral Bioavailability GLPG0555 Different Solid Formulations</brief_title>
	<detailed_description />
	<criteria>healthy male BMI 1830 kg/mÂ² , inclusive . significantly abnormal platelet function coagulopathy smoke drug alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>